Eisenhauer EA - Search Results

1

Phase II study of subcutaneous rHu-interleukin-2 and rHu-interferon alpha-2a in previously treated patients with multiple myeloma.

Belch AR, Eisenhauer EA, Muldal A, Browman G, Klasa R, Osterwalder B. Belch AR, et al. Among authors: eisenhauer ea. Ann Oncol. 1995 Sep;6(7):721-3. doi: 10.1093/oxfordjournals.annonc.a059290. Ann Oncol. 1995. PMID: 8664195 Free article. Clinical Trial.

2

Gemcitabine in advanced renal cell carcinoma. A phase II study of the National Cancer Institute of Canada Clinical Trials Group.

Mertens WC, Eisenhauer EA, Moore M, Venner P, Stewart D, Muldal A, Wong D. Mertens WC, et al. Among authors: eisenhauer ea. Ann Oncol. 1993 Apr;4(4):331-2. doi: 10.1093/oxfordjournals.annonc.a058494. Ann Oncol. 1993. PMID: 8518225 Free article. Clinical Trial.

3

A phase II study of bortezomib in mantle cell lymphoma: the National Cancer Institute of Canada Clinical Trials Group trial IND.150.

Belch A, Kouroukis CT, Crump M, Sehn L, Gascoyne RD, Klasa R, Powers J, Wright J, Eisenhauer EA. Belch A, et al. Among authors: eisenhauer ea. Ann Oncol. 2007 Jan;18(1):116-121. doi: 10.1093/annonc/mdl316. Epub 2006 Sep 13. Ann Oncol. 2007. PMID: 16971665 Free article. Clinical Trial.

4

Gemcitabine is an active new agent in previously untreated extensive small cell lung cancer (SCLC). A study of the National Cancer Institute of Canada Clinical Trials Group.

Cormier Y, Eisenhauer E, Muldal A, Gregg R, Ayoub J, Goss G, Stewart D, Tarasoff P, Wong D. Cormier Y, et al. Ann Oncol. 1994 Mar;5(3):283-5. doi: 10.1093/oxfordjournals.annonc.a058808. Ann Oncol. 1994. PMID: 8186176 Free article. Clinical Trial.

5

Docetaxel in advanced renal carcinoma. A phase II trial of the National Cancer Institute of Canada Clinical Trials Group.

Mertens WC, Eisenhauer EA, Jolivet J, Ernst S, Moore M, Muldal A. Mertens WC, et al. Among authors: eisenhauer ea. Ann Oncol. 1994 Feb;5(2):185-7. doi: 10.1093/oxfordjournals.annonc.a058776. Ann Oncol. 1994. PMID: 7910480 Free article. Clinical Trial.

6

Phase II study of weekly edatrexate as first-line chemotherapy for metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group study.

Vandenberg TA, Pritchard KI, Eisenhauer EA, Trudeau ME, Norris BD, Lopez P, Verma SS, Buckman RA, Muldal A. Vandenberg TA, et al. Among authors: eisenhauer ea. J Clin Oncol. 1993 Jul;11(7):1241-4. doi: 10.1200/JCO.1993.11.7.1241. J Clin Oncol. 1993. PMID: 8315420 Clinical Trial.

7

Docetaxel in patients with metastatic breast cancer: a phase II study of the National Cancer Institute of Canada-Clinical Trials Group.

Trudeau ME, Eisenhauer EA, Higgins BP, Letendre F, Lofters WS, Norris BD, Vandenberg TA, Delorme F, Muldal AM. Trudeau ME, et al. Among authors: eisenhauer ea. J Clin Oncol. 1996 Feb;14(2):422-8. doi: 10.1200/JCO.1996.14.2.422. J Clin Oncol. 1996. PMID: 8636752 Clinical Trial.

8

Flavopiridol in untreated or relapsed mantle-cell lymphoma: results of a phase II study of the National Cancer Institute of Canada Clinical Trials Group.

Kouroukis CT, Belch A, Crump M, Eisenhauer E, Gascoyne RD, Meyer R, Lohmann R, Lopez P, Powers J, Turner R, Connors JM; National Cancer Institute of Canada Clinical Trials Group. Kouroukis CT, et al. J Clin Oncol. 2003 May 1;21(9):1740-5. doi: 10.1200/JCO.2003.09.057. J Clin Oncol. 2003. PMID: 12735303 Clinical Trial.

9

Phase I clinical trial of recombinant human interleukin-3 combined with carboplatin in the treatment of patients with recurrent ovarian carcinoma.

Rusthoven JJ, Eisenhauer E, Mazurka J, Hirte H, O'Connell G, Muldal A, Lu HX, Onetto N, Swenerton K, Jeffrey J. Rusthoven JJ, et al. J Natl Cancer Inst. 1993 May 19;85(10):823-5. doi: 10.1093/jnci/85.10.823. J Natl Cancer Inst. 1993. PMID: 8487328 Clinical Trial. No abstract available.

10

A phase II study of bortezomib and gemcitabine in relapsed mantle cell lymphoma from the National Cancer Institute of Canada Clinical Trials Group (IND 172).

Kouroukis CT, Fernandez LA, Crump M, Gascoyne RD, Chua NS, Buckstein R, Turner R, Assouline S, Klasa RJ, Walsh W, Powers J, Eisenhauer E. Kouroukis CT, et al. Leuk Lymphoma. 2011 Mar;52(3):394-9. doi: 10.3109/10428194.2010.546015. Leuk Lymphoma. 2011. PMID: 21323520 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

280 results

Search Page

Filters